Infectious Diseases Manager
Grupo Ferrer International
Over 25 years experience in the pharmaceutical industry. Before joining Ferrer in 2008: Director of Drug Discovery Biology at GlaxoSmithKline (GSK). Responsible for the coordination of the scientific units (Microbiology, Parasitology, Cell Biology, Pharmacology, DMPK, Toxicology and Safety Pharmacology, in vitro and in vivo) and innovation activities for the evaluation and characterization of new compounds in the area of antifungal, antibacterial, and neglected infectious diseases (especially malaria and tuberculosis). Paying special attention to teamwork, communication between disciplines, and the streamlining of logistics processes between units with the aim of optimizing the use of resources and speeding up the processes of discovery and development of new drugs. Member of a large number of multidisciplinary international research teams which, as project leader, have led to the discovery of several first-in-class candidates in different projects. Responsible for the building and implementing activities in the Biology Area, including the design and construction of facilities, with biosafety laboratories and a state-of-the-art animal house, to work with category 3 infectious agents. In addition responsible for the coordination, supervision and approval of work procedures. Author of over 60 original peer-reviewed articles in international journals; book chapters; and patent applications. Director of 3 doctoral theses. Organizer and invited speaker at international scientific and strategic events. Guest lecturer in several Masters and postgraduate courses and presenter at international conferences. Recipient of several distinctions for excellence in research including the Henri Warembourg Faculty of Medicine Medal, awarded by the University of Lille; Medicines for Malaria Venture Project of the Year Awards 2003 and 2004; and four Silver and one Bronze GSK R&D Recognition Awards.